Company · CIK 0001444570
Aptalis Pharma Inc
Exchange
—
Entity type
operating
Fiscal year end
Sep 30
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- 8-KCurrent report0001193125-12-227793 · 14.6 KBSEC(opens sec.gov)
- 10-Q/AAptalis Pharma Inc0001193125-12-189922 · 801.2 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-12-094976 · 69.3 KBSEC(opens sec.gov)
- 10-QQuarterly update0001193125-12-052580 · 6.0 MBSEC(opens sec.gov)
- 8-KCurrent report0001193125-12-002200 · 15.3 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-11-348469 · 58.0 KBSEC(opens sec.gov)
- 10-KAnnual report0001193125-11-345928 · 9.4 MBSEC(opens sec.gov)
- 8-KCurrent report0001193125-11-284002 · 24.7 KBSEC(opens sec.gov)
- 8-KCurrent report0000950123-11-082131 · 21.0 KBSEC(opens sec.gov)
- 10-QQuarterly update0000950123-11-076768 · 5.2 MBSEC(opens sec.gov)
Insiders
No insiders on record.
Tickers
No tickers on record.
Addresses
business
22 INVERNESS CENTER PARKWAY SUITE 310
BIRMINGHAM, AL, 35242
mailing
22 INVERNESS CENTER PARKWAY SUITE 310
BIRMINGHAM, AL, 35242
Former names
- Axcan Intermediate Holdings Inc.2011-04-28
Same industry